Omniox, Inc.
PrivateLast Round
Grant
Jan 22, 2024
Total Funding Raised
$58.14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Omniox, Inc. operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Grant round in January 2024.
Omniox, Inc. is a biopharmaceutical company developing oxygen-delivery therapeutics to treat a range of diseases, including solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniox, Inc. Comparables
Compare Omniox, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NuvOx Therapeutics | 81% | |
| Prolong Pharmaceuticals, LLC | 80% | |
| Aurum Biosciences Ltd | 73% |
For institutional investors. Book with your work email.
Omniox, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 22, 2024 | ||||
| Early Funding | Nov 1, 2023 | ||||
| Series D | Mar 23, 2018 | ||||
| Grant | Aug 2, 2017 | ||||
| Grant | Sep 1, 2016 | ||||
Convertible Debt | Aug 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Omniox, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Wavemaker Three-Sixty Health | Early Funding |
| Samsara BioCapital | Early Funding |
| Medical Technology Enterprise Consortium | Grant |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development | Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 435% MoM to 5.2K.
- Jul 25, 2026
Monthly visitors increased 112% MoM.
For institutional investors. Book with your work email.
Omniox, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Omniox, Inc.'s valuation, stock price, and market status.
Is Omniox, Inc. a public or private company?
Omniox, Inc. is a private company.
What is the current stock price of Omniox, Inc.?
Omniox, Inc. is a private company, so its shares have no public market price. Caplight tracks Omniox, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Omniox, Inc. worth (valuation)?
Valuation information for Omniox, Inc. is not publicly available.
Can I buy Omniox, Inc. stock?
Omniox, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Omniox, Inc.'s last funding round?
Omniox, Inc.'s most recent funding round was Grant on January 22, 2024.
Who are the main investors in Omniox, Inc.?
Key investors in Omniox, Inc. include National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Wellcome Trust.
Will Omniox, Inc. IPO soon?
No public IPO plans have been announced for Omniox, Inc..
How can I track Omniox, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Omniox, Inc.'s shares on secondary markets.